Clinical Practice Guidelines (CPG) on EBMonFHIR
1.0.2 - ci-build
Clinical Practice Guidelines (CPG) on EBMonFHIR, published by Universitätsmedizin Greifswald. This guide is not an authorized publication; it is the continuous build for version 1.0.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/CEOsys/cpg-on-ebm-on-fhir/ and changes regularly. See the Directory of published versions
Draft as of 2022-09-06 |
{
"resourceType" : "CodeSystem",
"id" : "cs-evidence-to-decision-certainty-type",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-shareablecodesystem"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cs-evidence-to-decision-certainty-type</b></p><a name=\"cs-evidence-to-decision-certainty-type\"> </a><a name=\"hccs-evidence-to-decision-certainty-type\"> </a><a name=\"cs-evidence-to-decision-certainty-type-en-US\"> </a><p>This code system <code>https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-evidence-to-decision-certainty-type</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">benefit-and-harms<a name=\"cs-evidence-to-decision-certainty-type-benefit-and-harms\"> </a></td><td>Benefits and Harms</td><td>Summary of most important benefits and harms</td></tr><tr><td style=\"white-space:nowrap\">preference-and-values<a name=\"cs-evidence-to-decision-certainty-type-preference-and-values\"> </a></td><td>Preference and values</td><td>Typical patient preferences and values? Common issues or expected variability?</td></tr><tr><td style=\"white-space:nowrap\">resources<a name=\"cs-evidence-to-decision-certainty-type-resources\"> </a></td><td>Resources</td><td>Issues with costs or resource use? For whom? Cost-benefit analysis? Implementation or other issues?</td></tr><tr><td style=\"white-space:nowrap\">equity<a name=\"cs-evidence-to-decision-certainty-type-equity\"> </a></td><td>Equity</td><td>How do the different alternatives affect equity?</td></tr><tr><td style=\"white-space:nowrap\">acceptability<a name=\"cs-evidence-to-decision-certainty-type-acceptability\"> </a></td><td>Acceptability</td><td>Are the alternatives acceptable for the target population and its implementors?</td></tr><tr><td style=\"white-space:nowrap\">feasibility<a name=\"cs-evidence-to-decision-certainty-type-feasibility\"> </a></td><td>Feasibility</td><td>How feasible will it be to implement the different alternatives? Any issues?</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
"valueCode" : "shareable"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
"valueCode" : "computable"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
"valueCode" : "publishable"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
"valueCode" : "structured"
}
],
"url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-evidence-to-decision-certainty-type",
"version" : "0.1.1",
"name" : "EvidenceToDecisionCertaintyType",
"title" : "Evidence To Decision Certainty type",
"status" : "draft",
"date" : "2022-09-06",
"publisher" : "Netzwerk Universitätsmedizin (NUM)",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "https://www.netzwerk-universitaetsmedizin.de"
}
]
}
],
"description" : "GRADE Evidence to Decision (EtD) Framework Certainty Type",
"content" : "complete",
"count" : 6,
"concept" : [
{
"code" : "benefit-and-harms",
"display" : "Benefits and Harms",
"definition" : "Summary of most important benefits and harms"
},
{
"code" : "preference-and-values",
"display" : "Preference and values",
"definition" : "Typical patient preferences and values? Common issues or expected variability?"
},
{
"code" : "resources",
"display" : "Resources",
"definition" : "Issues with costs or resource use? For whom? Cost-benefit analysis? Implementation or other issues?"
},
{
"code" : "equity",
"display" : "Equity",
"definition" : "How do the different alternatives affect equity?"
},
{
"code" : "acceptability",
"display" : "Acceptability",
"definition" : "Are the alternatives acceptable for the target population and its implementors?"
},
{
"code" : "feasibility",
"display" : "Feasibility",
"definition" : "How feasible will it be to implement the different alternatives? Any issues?"
}
]
}